← Back to headlines
AbbVie revises guidance, expects Q2 EPS to include unfavorable $0.17 impact
AbbVie has revised its financial guidance, indicating that its second-quarter earnings per share (EPS) are expected to include an unfavorable impact of $0.17.
6 Jul, 20:44 — 6 Jul, 20:44
Sources
Showing 1 of 1 sources
